Skip to main content
Livermore
Livermore
ZHEN

Red Spruce Capital, LLC

SEC CIK
0001795356
Latest filing
Jul 7, 2026

ABT holding history

Abbott Laboratories in every 13F filed by Red Spruce Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
36,210
Value
$3.29M
% of portfolio
1.1%
Quarters held
22
Since Q1 2021
Holdings of ABT by Red Spruce Capital, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202636,210$3.29M1.1%+7,078+24.3%AddedHolders
Q1 202629,132$2.99M1.2%+1,406+5.1%AddedHolders
Q4 202527,726$3.47M1.4%−362−1.3%ReducedHolders
Q3 202528,088$3.76M1.5%−313−1.1%ReducedHolders
Q2 202528,401$3.86M1.7%−5,403−16.0%ReducedHolders
Q1 202533,804$4.48M2.1%−828−2.4%ReducedHolders
Q4 202434,632$3.92M1.7%+1,339+4.0%AddedHolders
Q3 202433,293$3.80M1.7%+578+1.8%AddedHolders
Q2 202432,715$3.40M1.6%+1,311+4.2%AddedHolders
Q1 202431,404$3.57M1.7%+2,388+8.2%AddedHolders
Q4 202329,016$3.19M1.6%+3,812+15.1%AddedHolders
Q3 202325,204$2.44M1.4%+41+0.2%AddedHolders
Q2 202325,163$2.74M1.5%+225+0.9%AddedHolders
Q1 202324,938$2.53M1.5%+1,423+6.1%AddedHolders
Q4 202223,515$2.58M1.6%+771+3.4%AddedHolders
Q3 202222,744$2.20M1.5%+914+4.2%AddedHolders
Q2 202221,830$2.37M1.6%−98−0.4%ReducedHolders
Q1 202221,928$2.60M1.5%+823+3.9%AddedHolders
Q4 202121,105$2.97M1.6%+172+0.8%AddedHolders
Q3 202120,933$2.47M1.4%+408+2.0%AddedHolders
Q2 202120,525$2.38M1.4%+359+1.8%AddedHolders
Q1 202120,166$2.42M1.5%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.